MedPath

Evaluation of blastocyst survival following vitrification and thawing using two methods - Fast Freeze™ Kit based on S3 and the Vit. Kit®

Not Applicable
Completed
Conditions
Reproductive medicine
Urological and Genital Diseases
Registration Number
ISRCTN41121428
Lead Sponsor
euven Institute for Fertility and Embryology (LIFE) (Belgium)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

1. Blastocysts derived from 1PN and 3PN embryos (abnormal embryos)
2. Blastocysts derived from biopsied and rejected embryo
3. Blastocysts derived from too fast or too slow embryos (that were neither transferred nor cryopreserved)
4. Blastocysts derived from culture of embryos (days 2 and 3) donated for scientific research

Exclusion Criteria

Still useful embryos and normal embryos not donated for scientific research

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath